Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 330

Results For "EY"

3769 News Found

Hilleman Laboratories invests US $ 58 mn to establish vaccine hub in Singapore
Biotech | December 07, 2021

Hilleman Laboratories invests US $ 58 mn to establish vaccine hub in Singapore

The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.


Wipro-GE unveils B2B e-commerce platform for medical equipment
Medical Device | December 07, 2021

Wipro-GE unveils B2B e-commerce platform for medical equipment

It is an extension of GE Healthcare’s online service delivery enterprise Service Shop


Study shows Glaxo-Vir drug works against Omicron mutations
News | December 07, 2021

Study shows Glaxo-Vir drug works against Omicron mutations

Data builds on promising signal published last week, underscoring the importance of sotrovimab for early treatment of COVID-19


Roche develops tests to identify Omicron variant
Medical Device | December 06, 2021

Roche develops tests to identify Omicron variant

Roche subsidiary TIB Molbiol rapidly developed additional testing options to differentiate mutations in the Omicron SARS-CoV-2 variant, as they continue to offer new and accurate detection solutions


AWS partners with Pfizer to accelerate drug development
Biotech | December 06, 2021

AWS partners with Pfizer to accelerate drug development

It works with Pfizer to support more rapid innovation and improved clinical manufacturing operations to help develop tomorrow’s therapies


Ophthalmologists converge in Chennai to discuss latest innovations
Events | December 05, 2021

Ophthalmologists converge in Chennai to discuss latest innovations

IIRSI 2021 aims to bring together ophthalmologists across India and abroad to discuss the advancement in technology and their experience in IOL implantation and Refractive Surgery


Morpen gets U.S. FDA approval for Fexofinadine
Drug Approval | December 05, 2021

Morpen gets U.S. FDA approval for Fexofinadine

Fexofinadine is the most widely used, second-generation antihistamine drug for the treatment of allergy symptoms and hay fever


Biocon Pharma receives ANDA approval for Mycophenolic acid
Drug Approval | December 03, 2021

Biocon Pharma receives ANDA approval for Mycophenolic acid

This further adds to Biocon’s portfolio of vertically integrated complex drug products


Novartis showcases its attractive growth pipeline
News | December 03, 2021

Novartis showcases its attractive growth pipeline

Focused medicines company delivering strong operational performance. Building depth in five core therapeutic areas, strength in technology platforms, and a balanced geographic footprint


Aster Volunteers offer free diabetes screening in India and UAE
Events | December 03, 2021

Aster Volunteers offer free diabetes screening in India and UAE

In 2019, diabetes was the ninth leading cause of death with an estimated 1.5 million deaths directly caused by diabetes, as per WHO